Issues relating to the STRONGER Patents Act and Section 101 reform
Issues related to MDUFA implementation
Issues relating to the medical product supply chain
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices
Issues related to PFAS Chemical regulation
Issues related to the Valid Act of 2023 - H.R. 2369
Issues related to cyber security
Issues related to Public Health Emergency Preparedness
Issues related to consumer and health data privacy
Issues related to privacy legislation
Issues related to the use of Artificial Intelligence
Issues related to Medicare coverage reform
Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET
Issues related to the New Technology Add on Payment (NTAP)
Issues related to Medicare coverage for digital health technologies
Issues related to coverage of telehealth services
Issues related to physician fee schedule
Issues related to CMS expansion of prior authorization requirements for medical procedures
Issues related to R&D Tax Credit
Duration: October 1, 2017
to
present
General Issues: Copyright/Patent/Trademark , Health Issues , Medicare/Medicaid , Taxation/Internal Revenue Code , Science/Technology
Spending: about $7,800,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: U.S. Senate, House of Representatives, Patent & Trademark Office (PTO), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on April 16.
Original Filing: 301551124.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to MDUFA implementation
Issues relating to the medical product supply chain
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices
Issues related to PFAS Chemical regulation
Issues related to the Valid Act of 2023 - H.R. 2369
Issues related to cyber security
Issues related to Public Health Emergency Preparedness
Issues related to consumer and health data privacy
Issues related to privacy legislation
Issues related to the use of Artificial Intelligence
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Medicare coverage reform
Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET
Issues related to the New Technology Add on Payment (NTAP)
Issues related to Medicare coverage for digital health technologies
Issues related to coverage of telehealth services
Issues related to physician fee schedule
Issues related to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to R&D Tax Credit
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2023
In Q4, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Jan. 18.
Original Filing: 301528682.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to MDUFA implementation
Issues relating to the medical product supply chain
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices
Issues related to PFAS Chemical regulation
Issues related to the Valid Act of 2023 - H.R. 2369
Issues related to cyber security
Issues related to Public Health Emergency Preparedness
Issues related to consumer and health data privacy
Issues related to privacy legislation
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Medicare coverage reform
Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET
Issues related to the New Technology Add on Payment (NTAP)
Issues related to Medicare coverage for digital health technologies
Issues related to coverage of telehealth services
Issues related to physician fee schedule
Issues related to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to R&D Tax Credit
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2023
In Q3, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Oct. 19, 2023.
Original Filing: 301507166.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to MDUFA implementation
Issues relating to the medical product supply chain
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices
Issues related to PFAS Chemical regulation
Issues related to the Valid Act of 2023 - H.R. 2369
Issues related to cyber security
Issues related to Public Health Emergency Preparedness
Issues related to consumer and health data privacy
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Medicare coverage reform
Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET
Issues related to the New Technology Add on Payment (NTAP)
Issues related to Medicare coverage for digital health technologies
Issues related to coverage of telehealth services
Issues related to physician fee schedule
Issues related to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to R&D Tax Credit
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2023
In Q2, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on July 18, 2023.
Original Filing: 301479589.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to MDUFA implementation
Issues relating to FDA Covid-19 Response
Issues relating to the medical product supply chain
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices
Issues related to the Valid Act of 2023 - H.R. 2369
Issues related to cyber security
Issues related to Public Health Emergency Preparedness
Issues related to consumer and health data privacy
Issues related to PFAS Chemical regulation
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Medicare coverage reform
Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET
Issues related to the New Technology Add on Payment (NTAP)
Issues related to Medicare coverage for digital health technologies
Issues related to coverage of telehealth services
Issues related to physician fee schedule
Issues related to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to R&D Tax Credit
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2023
In Q1, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on April 17, 2023.
Original Filing: 301452862.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to MDUFA implementation
Issues related to H.R. 7667, Food and Drug Amendments of 2022
Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act
Issues relating to FDA Covid-19 Response
Issues relating to the medical product supply chain
Issues relating to S. 3799, PREVENT Pandemics Act
Issues related to CURES 2.0
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices
Issues related to the Valid Act of 2021 - H.R. 4128/S.2209
Issues related to cyber security including H.R. 7084/ S. 3983, PATCH Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Medicare coverage reform
Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act
Issues related to Medicare coverage for digital health technologies
Issues related to coverage of telehealth services
Issues related to physician fee schedule
Issues relating to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to R&D Tax Credit
Issues related to R&D expense amortization
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the America COMPETES Act
Issues relating to the United States Innovation and Competition Act (USICA)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Jan. 18, 2023.
Original Filing: 301430486.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to R&D Tax Credit
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the America COMPETES Act, Issues relating to the United States Innovation and Competition Act (USICA)
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2022
In Q3, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Oct. 18, 2022.
Original Filing: 301406750.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to IGNITE America Innovation Act, Issues related to R&D Tax Credit
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the America COMPETES Act, Issues relating to the United States Innovation and Competition Act (USICA)
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2022
In Q2, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on July 13, 2022.
Original Filing: 301379900.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the Build Back Better Plan, Issues relating to the PREVENT Pandemics Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax proposals to provide liquidity for startups (IGNITE Act)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the America COMPETES Act, Issues relating to the United States Innovation and Competition Act (USICA)
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2022
In Q1, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on April 19, 2022.
Original Filing: 301362822.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the Build Back Better Plan, Issues relating to the PREVENT Pandemics Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax proposals to provide liquidity for startups (IGNITE Act)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the America COMPETES Act, Issues relating to the United States Innovation and Competition Act (USICA)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2021
In Q4, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Jan. 20, 2022.
Original Filing: 301331482.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the Build Back Better Plan
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax proposals to provide liquidity for startups (IGNITE Act)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2021
In Q3, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301304243.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the Build Back Better Plan
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax proposals to provide liquidity for startups (IGNITE Act)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2021
In Q2, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on July 8, 2021.
Original Filing: 301274319.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the American Rescue Plan
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax proposals to provide liquidity for startups (IGNITE Act)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2021
In Q1, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on April 20, 2021.
Original Filing: 301265956.xml
Lobbying Issues
Issues relating to the STRONGER Patents Act and Section 101 reform
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the American Rescue Plan
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax proposals to provide liquidity for startups (IGNITE Act)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2020
In Q4, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Jan. 15, 2021.
Original Filing: 301231562.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices, The CARES Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax solutions for COVID-19 relief
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2020
In Q3, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Oct. 8, 2020.
Original Filing: 301208075.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices, The CARES Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax solutions for COVID-19 relief
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2020
In Q2, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on July 13, 2020.
Original Filing: 301187167.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices, The CARES Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax solutions for COVID-19 relief
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2020
In Q1, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on April 20, 2020.
Original Filing: 301173683.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices, The CARES Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the Medical Device Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2019
In Q4, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Jan. 8, 2020.
Original Filing: 301103716.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the Medical Device Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2019
In Q3, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Oct. 8, 2019.
Original Filing: 301063884.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the Medical Device Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2019
In Q2, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on July 9, 2019.
Original Filing: 301043768.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the Medical Device Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2019
In Q1, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on April 15, 2019.
Original Filing: 301025328.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the Medical Device Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2018
In Q4, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Jan. 8, 2019.
Original Filing: 301002693.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the Medical Device Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2018
In Q3, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Oct. 10, 2018.
Original Filing: 300984023.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the Medical Device Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2018
In Q2, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on July 9, 2018.
Original Filing: 300962840.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the Medical Device Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2018
In Q1, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on April 5, 2018.
Original Filing: 300942582.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the Medical Device Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2017
In Q4, MEDICAL DEVICE MANUFACTURERS ASSOCIATION had in-house lobbyists. The report was filed on Jan. 3, 2018.
Original Filing: 300921122.xml
Lobbying Issues
Issues relating to the Patent Reform Act
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to Reimbursement of Medical Devices
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the Medical Device Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...